Measuring the impact of learning with AI in Sierra Leone and beyond
Results from a randomized controlled trial show the potential of Gemini’s Guided Learning feature to boost engagement and accelerate learning.
More from the blog
Transfer learning for genomic prediction in underrepresented populations
General Science
BenchMIRT: What are LLM benchmarks actually measuring?
Mapping global methane emissions from space with deep learning
Climate & Sustainability
Looking beyond natural sequences
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.
Related papers
Token-Mol 1.0: tokenized drug design with large language models
The integration of large language models (LLMs) into drug design is gaining momentum; however, existing approaches often struggle to effectively incorporate three-dimensional molecular structures. Here, we present Token-Mol, a token-only 3D drug design model that encodes both 2D and 3D structural information, along with molecular properties, into discrete tokens. Built on a transformer decoder and trained with causal masking, Token-Mol introduces a Gaussian cross-entropy loss function tailored for regression tasks, enabling superior performance across multiple downstream applications. The model surpasses existing methods, improving molecular conformation generation by over 10% and 20% across two datasets, while outperforming token-only models by 30% in property prediction. In pocket-based molecular generation, it enhances drug-likeness and synthetic accessibility by approximately 11% and 14%, respectively. Notably, Token-Mol operates 35 times faster than expert diffusion models. In real-world validation, it improves success rates and, when combined with reinforcement learning, further optimizes affinity and drug-likeness, advancing AI-driven drug discovery. In this work the authors present Token-Mol, a token-only 3D drug design model, which deploys the Gaussian cross-entropy (GCE) loss function for regression tasks. It exhibits superior performance in molecular conformation generation, property prediction, and pocket-based generation, thus opening up new avenues for drug design.
mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive dataset
Designing effective mRNA sequences for therapeutics remains a formidable challenge. Inspired by successes in protein design, language models (LMs) are now being applied to RNA, but progress is often impeded by the lack of comprehensive training data. Existing models are frequently limited to UTR or CDS regions, restricting their application for complete mRNA sequences. We introduce mRNABERT, a robust, all-in-one mRNA designer pre-trained on the largest available mRNA dataset. To enhance performance, we propose a dual tokenization scheme with a cross-modality contrastive learning framework to integrate semantic information from protein sequences. On a comprehensive benchmark, mRNABERT demonstrates state-of-the-art performance, outperforming previous models in the majority of tasks for 5’ UTR and CDS design, RNA-binding protein (RBP) site prediction, and full-length mRNA property prediction. It also surpasses large protein models in several related tasks. In conclusion, mRNABERT’s superior performance across these diverse tasks signifies a substantial leap forward in mRNA research and therapeutic development. Designing complete mRNA sequences for new vaccines and therapies is a complex challenge. Here, the authors develop mRNABERT, a foundational AI model that designs entire mRNA sequences and demonstrates superior performance across comprehensive benchmarks.
Time for AI (Ethics) Maturity Model Is Now
There appears to be a common agreement that ethical concerns are of high importance when it comes to systems equipped with some sort of Artificial Intelligence (AI). Demands for ethical AI are declared from all directions. As a response, in recent years, public bodies, governments, and universities have rushed in to provide a set of principles to be considered when AI based systems are designed and used. We have learned, however, that high-level principles do not turn easily into actionable advice for practitioners. Hence, also companies are publishing their own ethical guidelines to guide their AI development. This paper argues that AI software is still software and needs to be approached from the software development perspective. The software engineering paradigm has introduced maturity model thinking, which provides a roadmap for companies to improve their performance from the selected viewpoints known as the key capabilities. We want to voice out a call for action for the development of a maturity model for AI software. We wish to discuss whether the focus should be on AI ethics or, more broadly, the quality of an AI system, called a maturity model for the development of AI systems.
Unified and explainable molecular representation learning for imperfectly annotated data from the hypergraph view
Molecular representation learning (MRL) has shown promise in accelerating drug development by predicting chemical properties. However, imperfectly annotation among datasets pose challenges in model design and explainability. In this work, we formulate molecules and corresponding properties as a hypergraph, extracting three key relationships: among properties, molecule-to-property, and among molecules, and developed a unified and explainable multi-task MRL framework, OmniMol. It integrates a task-related meta-information encoder and a task-routed mixture of experts (t-MoE) backbone to capture correlations among properties and produce task-adaptive outputs. To capture underlying physical principles among molecules, we implement an innovative SE(3)-encoder for physical symmetry, applying equilibrium conformation supervision, recursive geometry updates, and scale-invariant message passing to facilitate learning-based conformational relaxation. OmniMol achieves state-of-the-art performance in properties prediction, reaches top performance in chirality-aware tasks, demonstrates explainability for all three relations, and shows effective performance in practical applications. Our code is available in our https://github.com/bowenwang77/OmniMol public repository. AI models for drug discovery often struggle with real-world, incomplete data. Here, the authors present OmniMol, a framework using hypergraphs to improve predictions of molecular properties, addressing challenges of imperfect data annotation and enhancing model explainability.